Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “1- Women”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT06223776
What this trial is testing

Effects of Sleep Restrictions on Maximal Strength, Muscle Power, and Strength Endurance in Resistance-trained Women.

Who this might be right for
Sleep RestrictionSleep
University School of Physical Education, Krakow, Poland 20
Early research (Phase 1)Looking for participantsNCT06515613
What this trial is testing

CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors

Who this might be right for
Platinum-resistant Ovarian CancerTesticular CancerEndometrial Cancer
Context Therapeutics Inc. 156
Not applicableUnknownNCT03915990
What this trial is testing

Middle Cerebral and Umbilical Arteries Doppler Indices in the Prediction of Adverse Neonatal Outcome Among Diabetic Pregnant Women

Who this might be right for
Diabetes Mellitus, Type 1
Cairo University 120
Early research (Phase 1)Study completedNCT05083949
What this trial is testing

A Study in Healthy Humans to Assess the Relative Bioavailability of One Fixed-dose Combination Tablet Empagliflozin/Metformin Versus Jardiance® Tablet and Glifage® Tablet Administered Together

Who this might be right for
Healthy
Boehringer Ingelheim 32
Not applicableStudy completedNCT00165152
What this trial is testing

Counseling Interventions for BRCA 1/2 Cancer Susceptibility Testing

Who this might be right for
Breast CancerOvarian Cancer
Dana-Farber Cancer Institute 150
Early research (Phase 1)Study completedNCT04267250
What this trial is testing

Effect Of Multiple Dose PF-06700841 On The Pharmacokinetics Of Single Dose Oral Contraceptive Steroids

Who this might be right for
Healthy Female Volunteers
Pfizer 18
Early research (Phase 1)Study completedNCT04641260
What this trial is testing

Assess the Effect of Food With Fezolinetant in Healthy Female Participants

Who this might be right for
Healthy Subjects
Astellas Pharma Global Development, Inc. 16
Early research (Phase 1)Active Not RecruitingNCT04255147
What this trial is testing

Cellular Therapy for Extreme Preterm Infants at Risk of Developing Bronchopulmonary Dysplasia

Who this might be right for
Bronchopulmonary Dysplasia
Ottawa Hospital Research Institute 9
Testing effectiveness (Phase 2)Looking for participantsNCT04104776
What this trial is testing

Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

Who this might be right for
Advanced Solid TumorDiffuse Large B Cell LymphomaLymphoma, T-Cell+5 more
Novartis Pharmaceuticals 300
Testing effectiveness (Phase 2)Ended earlyNCT03342417
What this trial is testing

Combination of Nivolumab and Ipilimumab in Breast, Ovarian and Gastric Cancer Patients

Who this might be right for
Breast Cancer FemaleOvarian CancerGastric Cancer
ExcellaBio LLC 5
Early research (Phase 1)Ended earlyNCT02943317
What this trial is testing

Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Clinical Activity of Defactinib in Combination With Avelumab in Epithelial Ovarian Cancer

Who this might be right for
Epithelial Ovarian Cancer
Verastem, Inc. 98
Not applicableLooking for participantsNCT06343974
What this trial is testing

Noninvasive Evaluation of Fetal Hyperinsulinemia With Ultrasound Radiomics

Who this might be right for
Pregnancy in DiabeticDiabetes Mellitus, Type 1
Turku University Hospital 60
Not applicableLooking for participantsNCT03788213
What this trial is testing

One Week Versus Three Week in Adjuvant Radiotherapy in Breast Cancer

Who this might be right for
Breast Cancer Female
Tata Medical Center 2,100
Early research (Phase 1)Ended earlyNCT05740280
What this trial is testing

ICP-NI - Safety, Tolerability, Pharmacokinetic, and Immunogenicity Study in Healthy Male and Female Subjects

Who this might be right for
Healthy Volunteers
Cellivery Therapeutics, Inc. 24
Not applicableStudy completedNCT04171297
What this trial is testing

Ultrasound Evaluation of the Pelvis in Women with Suspected Endometriosis Scheduled for Laparoscopic Surgery

Who this might be right for
Gynecologic DiseaseEndometriosisEndometriosis, Rectum+5 more
Universitaire Ziekenhuizen KU Leuven 1,866
Early research (Phase 1)Active Not RecruitingNCT04670068
What this trial is testing

Phase I Study of Autologous CAR T-Cells Targeting the B7-H3 Antigen in Recurrent Epithelial Ovarian

Who this might be right for
Epithelial Ovarian Cancer
UNC Lineberger Comprehensive Cancer Center 4
Not applicableStudy completedNCT01643148
What this trial is testing

The Tetrad BMI, Leptin, Leptin/Adiponectin (L/A) Ratio and CA-15-3 is a Reliable Biomarker of Breast Cancer

Who this might be right for
Female Breast Carcinoma
Materno-Perinatal Hospital of the State of Mexico 88
Testing effectiveness (Phase 2)Study completedNCT04495608
What this trial is testing

Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Fluconazole in Hypercalcicuric Patients With Increased 1.25(OH) 2D Levels

Who this might be right for
NephrolithiasisNephrocalcinosisHypercalciuria
Hospices Civils de Lyon 56
Early research (Phase 1)Study completedNCT01511497
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study Of PF-04427429 In Healthy Women Volunteers

Who this might be right for
PainMigraine Disorders
Pfizer 31
Not applicableStudy completedNCT04237480
What this trial is testing

Influence of Kidney Performance and Magnesium on Formation of (OH)2-vitamin D3

Who this might be right for
Hydroxylase Deficiency
University Hospital, Basel, Switzerland 50,000
Next Page